Period I: 1992 – 95 | Period II: 1996 - 99 | Period III: 2000 - 03 | Period interactions | ||||||
---|---|---|---|---|---|---|---|---|---|
Income | RR | 95% CI | RR | 95% CI | RR | 95% CI | p value | ||
All cause mortality | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.35 | (1.18 - 1.54 ) | 1.39 | (1.20 - 1.61 ) | 1.41 | (1.23 - 1.61 ) | PII vs PIII | <.001 | |
3 | 1.67 | (1.49 - 1.88 ) | 1.77 | (1.55 - 2.02 ) | 1.80 | (1.58 - 2.04 ) | PI vs PIII | <.001 | |
2 | 2.15 | (1.89 - 2.44 ) | 2.41 | (2.10 - 2.77 ) | 2.60 | (2.26 - 3.00 ) | |||
1 | 2.89 | (2.54 - 3.28 ) | 3.49 | (3.03 - 4.03 ) | 4.17 | (3.57 - 4.88 ) | |||
Total disease mortality | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.36 | (1.19 - 1.57 ) | 1.41 | (1.22 - 1.64 ) | 1.42 | (1.24 - 1.63 ) | PII vs PIII | <.001 | |
3 | 1.67 | (1.47 - 1.89 ) | 1.77 | (1.54 - 2.03 ) | 1.81 | (1.59 - 2.06 ) | PI vs PIII | <.001 | |
2 | 2.07 | (1.81 - 2.38 ) | 2.32 | (2.01 - 2.769) | 2.53 | (2.17 - 2.94 ) | |||
1 | 2.59 | (2.28 - 2.95 ) | 3.18 | (2.73 - 3.71 ) | 3.82 | (3.23 - 4.52 ) | |||
Total amenable mortality | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.20 | (0.99 - 1.45 ) | 1.46 | (1.19 - 1.78 ) | 1.35 | (1.10 - 1.66 ) | PII vs PIII | 0.09 | |
3 | 1.46 | (1.23 - 1.73 ) | 1.68 | (1.42 - 1.99 ) | 1.65 | (1.39 - 1.97 ) | PI vs PIII | <.001 | |
2 | 1.90 | (1.59 - 2.267) | 2.31 | (1.91 - 2.80 ) | 2.43 | (1.98 - 2.97 ) | |||
1 | 2.83 | (2.40 - 3.33 ) | 3.91 | (3.27 - 4.68 ) | 4.13 | (3.37 - 5.06 ) | |||
Early detection and intervention | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.11 | (0.94 - 1.29 ) | 1.37 | (1.18 - 1.60 ) | 1.28 | (1.08 - 1.53 ) | PII vs PIII | 0.49 | |
3 | 1.31 | (1.14 - 1.50 ) | 1.53 | (1.35 - 1.74 ) | 1.47 | (1.27 - 1.70 ) | PI vs PIII | <.001 | |
2 | 1.61 | (1.40 - 1.85 ) | 1.87 | (1.61 - 2.19 ) | 1.98 | (1.66 - 2.35 ) | |||
1 | 2.00 | (1.75 - 2.27 ) | 2.67 | (2.26 - 3.16 ) | 2.66 | (2.25 - 3.15 ) | |||
- malignant neoplasm | |||||||||
5 | 1.00 | * | 1.00 | 1.00 | PI vs PII | 0.09 | |||
4 | 0.85 | (0.66 - 1.08 ) | 1.10 | (0.94 - 1.28 ) | 1.05 | (0.85 - 1.31 ) | PII vs PIII | 0.05 | |
3 | 0.78 | (0.63 - 0.97 ) | 1.12 | (0.97 - 1.29 ) | 1.02 | (0.85 - 1.21 ) | PI vs PIII | 0.46 | |
2 | 0.98 | (0.79 - 1.21 ) | 1.18 | (1.03 - 1.35 ) | 1.21 | (1.03 - 1.41 ) | |||
1 | 0.90 | (0.75 - 1.08 ) | 1.25 | (1.01 - 1.55 ) | 1.31 | (1.04 - 1.64 ) | |||
- hypertension and cerebrovascular disease | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.21 | (1.03 - 1.43 ) | 1.51 | (1.27 - 1.79 ) | 1.41 | (1.13 - 1.76 ) | PII vs PIII | 0.25 | |
3 | 1.52 | (1.32 - 1.75 ) | 1.71 | (1.49 - 1.97 ) | 1.72 | (1.43 - 2.05 ) | PI vs PIII | <.001 | |
2 | 1.85 | (1.60 - 2.15 ) | 2.19 | (1.85 - 2.59 ) | 2.39 | (1.94 - 2.96 ) | |||
1 | 2.37 | (2.06 - 2.72 ) | 3.23 | (2.72 - 3.84 ) | 3.35 | (2.75 - 4.07 ) | |||
-Improved treatment and medical care | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.46 | (1.07 - 1.97 ) | 1.69 | (1.20 - 2.39 ) | 1.57 | (1.18 - 2.08 ) | PII vs PIII | 0.03 | |
3 | 1.87 | (1.41 - 2.48 ) | 2.09 | (1.50 - 2.21 ) | 2.25 | (1.74 - 2.92 ) | PI vs PIII | <.001 | |
2 | 2.77 | (2.06 - 3.71 ) | 3.74 | (2.75 - 5.09 ) | 4.01 | (3.06 - 5.26 ) | |||
1 | 5.47 | (4.16 - 7.19 ) | 7.93 | (5.93 - 10.6 ) | 9.43 | (7.32 - 12.1 ) | |||
- predominantly primary care | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | 0.07 | ||||
4 | 1.95 | (1.29 - 2.93 ) | 1.54 | (1.02 - 2.32 ) | 2.14 | (1.18 - 3.88 ) | PII vs PIII | 0.06 | |
3 | 2.61 | (1.84 - 3.72 ) | 2.18 | (1.39 - 3.43 ) | 4.01 | (2.32 - 6.93 ) | PI vs PIII | <.001 | |
2 | 3.90 | (2.79 - 5.44 ) | 5.07 | (3.20 - 8.02 ) | 6.66 | (3.84 - 11.5 ) | |||
1 | 5.87 | (4.00 - 8.62 ) | 7.84 | (5.09 - 12.0 ) | 14.00 | (8.25 - 23.8 ) | |||
- predominantly specialist care | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | <.001 | ||||
4 | 1.35 | (0.97 - 1.87 ) | 1.71 | (1.19 - 2.45 ) | 1.47 | (1.08 - 2.01 ) | PII vs PIII | 0.06 | |
3 | 1.73 | (1.27 - 2.34 ) | 2.05 | (1.42 - 2.95 ) | 2.04 | (1.56 - 2.67 ) | PI vs PIII | <.001 | |
2 | 2.57 | (1.88 - 3.51 ) | 3.54 | (2.56 - 4.90 ) | 3.69 | (2.80 - 4.87 ) | |||
1 | 5.31 | (3.97 - 7.11 ) | 7.95 | (5.88 - 10.8 ) | 8.77 | (6.76 - 11.4 ) | |||
Ischaemic heart disease (IHD) | |||||||||
5 | 1.00 | 1.00 | 1.00 | PI vs PII | 0.115* | ||||
4 | 1.59 | ( 1.19 -2.12) | 1.42 | ( 1.12 - 1.81) | 1.52 | ( 1.10 - 2.09) | PII vs PIII | 0.002 | |
3 | 2.04 | ( 1.56 - 2.67) | 1.90 | ( 1.51 - 2.39 | 1.93 | ( 1.46 - 2.55) | PI vs PIII | 0.001 | |
2 | 2.54 | ( 1.93 - 3.32) | 2.58 | ( 2.10 - 3.17) | 2.95 | ( 2.17 - 4.01) | |||
1 | 3.51 | ( 2.66 - 4.62) | 3.90 | ( 3.13 - 4.86) | 4.74 | ( 3.44 - 6.52) |